tankyrase inhibitors (Institute of Cancer Research/Merck Serono)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Nametankyrase inhibitors (Institute of Cancer Research/Merck Serono)
Drug Alias Nametankyrase inhibitors (Institute of Cancer Research)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTankyrase inhibitors
TargetsTankyrase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaInstitute Of Cancer Research
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A